Publication: “Rationalizing recommendations for influenza and COVID-19 vaccines”

Rationalizing recommendations for influenza and COVID-19 vaccines
Jessica A. Breznik, Matthew S. Miller, Dawn M.E. Bowdish
Article 127775

Supplementary Tables and references

Bluesky Explainer here.

I’m excited to share our review “Rationalizing recommendations for influenza and COVID-19 vaccines”, which we feel makes a strong case for universal influenza and COVID-19 vaccination policies. With almost 500 references & 8 supplementary tables it’s a beast so let me break it down for you….1/n

https://www.sciencedirect.com/science/article/pii/S0264410X25010722#ec0005

We started this >a year ago after conversations with immunologists, policy-makers, and the general public. We felt there were misunderstandings about how well COVID-19 vaccines work. We argue that they work as well or better than influenza vaccines so vaccination policies should be similar. 2/n

Like influenza, everyone but newborns has been exposed to COVID-19 through either vaccination or infection so we only reviewed studies in the post-Omicron/post-vaccine era. There is no doubt that the burden of disease has changed in the Omicron/vaccine era, but does that mean COVID is over? 3/n

Comparable data is hard to find, but when we looked at 2022/23 & 2023/24 data we see that deaths are still higher for COVID than influenza BUT looking at % hides the fact that COVID-19 is more contagious and in 23/24 there were almost 3x as many COVID hospitalizations than influenza. 4/n

There’s a common belief that COVID-19 vaccines don’t provide very good protection against symptomatic infection -is this true? These data are very, very hard to compile because the pace of variant replacement and vaccine changes has been dizzying 5/n

Before we get to the data – I just want to give a huge shoutout to @belongia.bsky.social for leading so many high quality studies on influenza effectiveness – look how easy to compare year-to-year. 6/n

Now look at how complicated it is to compare COVID-19 vaccine effectiveness. In influenza studies it is often possible to assess which strain a person was infected with so you can assess vaccine effectiveness by strain. COVID-19 vaccines are almost never matched with the circulating variants.. 7/n

…but despite that disadvantage, levels of protection from symptomatic infection and severe disease are similar between COVID & influenza vaccines. Note that protection against symptomatic infection is VERY hard to estimate because people who don’t get sick don’t get tested. 8/n

There has been some frustration that COVID-19 vaccines don’t last longer but neither does protection from either infection or vaccination for other viruses. When we compare protection < 3 months and > 3 months, COVID-19 vaccines look pretty good, esp considering rapid variant change 9/n

We also make a case to increase to increase the range of vulnerable populations. Canada has been a leader in including congregate living and equity-deserving groups in priority populations (#elbowsup !) but people living with lung and heart issues should be included 10/n.

Vaccine programs are decided by more than efficacy and efficacy – here’s a summary of what the National Advisory Council on Immunization (Canada) includes. Our review doesn’t address the programmatic, cost, and social considerations, which are also important. 11/n

There are still a lot of unknowns, but we feel strongly that universal & free COVID-19 and influenza vaccines would be a good investment in health, health systems, and attendance at work and school. Thank you to the brilliantly detail oriented Dr.@jabreznik.bsky.social and infl Dr Matt Miller Fin!

Publication: “Mapping the intersection of demographics, behavior, and government response to the COVID-19 pandemic: an observational cohort study”

Kennedy, K.M., DeJong, E.N., Chan, A.W. et al. Mapping the intersection of demographics, behavior, and government response to the COVID-19 pandemic: an observational cohort study. BMC Glob. Public Health3, 52 (2025). https://doi.org/10.1186/s44263-025-00162-w

Bluesky Explainer thread by Dr. Kate Kennedy here:

Publication: “No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations”

Benoit, J.M., Breznik, J.A., Wu, Y. et al. No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations. Nat Commun16, 5219 (2025). https://doi.org/10.1038/s41467-025-60216-3

Below is an ‘explainer’ thread from Bluesky. See original here

Publication alert: “No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations” ‪@natcomms.nature.com‬ The backstory is particularly interesting-it’s a tale of the conflicting needs of scientists & decision makers in times of disinformation ….1/n

To begin – my team was funded by the CITF to study COVID-19 infections/vaccinations in older adults & people on immunosuppressants. We had a broad mandate to look at ‘cellular & humoral immunity’ and unlike most grants there was a constant feedback to decision makers, participants & the public 2/n https://www.covid19immunitytaskforce.ca/

This meant that I got a pretty good sense of people’s worries and concerns and we could get solid data to address them. Case in point – we provided data that long-term care residents needed a 3rd dose and then a 4th – they got them and colleagues proved they prevented many infections 3/n https://www.bmj.com/content/378/bmj-2022-071502.short

In 2021 internet personalities were fretting that too many vaccines would lead to ‘immune exhaustion’. Most immunologists were not worried (explanation to follow) but I was shocked to hear in meetings that some folks on decision making tables were worried, esp, for vulnerable populations 4/n

What is this scary ‘immune exhaustion’? When you turn on an inflammatory response (e.g., by vaccination/infection) you have to have a way to turn it off. T cells that recognize an antigen multiply, make cytokines and start to express ‘off-switches’ which have names like PD-1, Tim-3 & Lag-3. 5/n

When there is a lot of antigen around (ie. during infection or vaccination) the balance between the on-switch (antigen-stimulation) and the off-switch (PD-1 & friends) favours being on – the T cells expand & differentiate & work their magic. Here PD1 is better described as an ‘activation marker’….. 6/n

…than an exhaustion marker. When the antigen decreases (ie infection or vaccine clears), the off-switches signal that it’s time to close up the inflammatory shop. It is pretty rare that antigens don’t go away but in cancer that chronic stimulation can lead to sustained expression of the PD1 off-switch. 7/n

How do you know when a T cell is truly ‘exhausted’? It expressed these markers AND it loses its function. Here’s where our study shines – we looked at the T cells’ ability to produce at least 1 cytokine (‘functionality’) or more than 1 cytokine (‘polyfunctionality’). 8/n

Repeat vaccination does not affect the T cells ability to make cytokines, even in vulnerable populations. They may express some activation markers but they are definitely not turned off. 9/n

Pity the lead author, PhD student @jennabenoit.bsky.social‬ Her committee would grill her ‘why are you doing this- we all know vaccines don’t cause exhaustion!’ She held strong “Because policymakers & the public need us to PROVE this in THESE people”-She was strong, thorough & committed. 10/n

So why do so many people make such rash statements on whether a T cell is doing it’s thing (PD-1 = activation) vs crashing out (PD-1 =exhausted)? Above I said this disinformation began circulating in 2021 – we’ve been working on this story since then 11/n

Measuring 1 marker (eg PD1) and making wild inferences is relatively cheap & quick but measuring T cell function and analyzing these complex data is slow & expensive. Indeed we had a team of people working very hard in a clinical trials quality immune testing lab and an analysis team to generate these data. 12/n
https://healthresearch.healthsci.mcmaster.ca/single-cell-spatial-profiling-core-facility/human-immune-monitoring-services/

Learnings: Disinformation = quick to make up but hard to disprove and even immunologists and experts can have seeds of doubt sown by bad actors. Vulnerable populations deserve to be included in research. Negative data studies are impt but hard to sell (see reviews of the paper!). 13/n

Huge shout out to lead author @jennabenoit.bsky.social‬ and the not-on-Bluesky team from our star phlebotomist/blood processor Braeden Cowbrough, flow cytometry genius Dr. Jessica Breznik, analytics guru Dr. Chris Verschoor, and HITS Team (Nichols, Hagerman, Bramson) and of course our participants. 14/14

Dr. Bowdish’s “The Perils of Being Born in the Fall” is playing at the Toronto Fringe Festival, July 2-12th

Born in September? This professor has got bad news for you. Spend an hour of edu-tainment touring through the wackiness of early 19th century psychiatry, stealth mid-century reproductive rights activism, the climate/pregnancy connection, and learn why cold & flu season has an outsize impact on mental health. Didn’t think science could be funny? Come check out the only show in this year’s Fringe put on by a PhD scientist – you might laugh, but you’ll definitely learn. Tickets are “Pay What You Can” and available for as little as $4! Suitable for ages 13+ (PG). Content warning: brief mention of suicidality, mentions of mental health, abortion and reproductive sex.

Show times are:

2nd July 5:00pm
4th July 8:15pm
5th July 1:00pm
7th July 4:45pm
8th July 2:30pm
10th July 4:15pm
12th July 10:15pm

Helen Gardiner Phelan Playhouse
79 St George St, Toronto, ON M5S 3L8

For details and tickets: https://fringetoronto.com/fringe/show/perils-being-born-fall

Post-doctoral position in Human Immunology Available

About the project

              The Bowdish lab has received funding from the Canadian Institute for Health Research (CIHR) to study immune responses to SARS-CoV-2 infections and vaccinations in older adults including those living in long-term care. The applicant will use over 10,000 biobanked saliva, PBMCs, and serum from over 500 participants in addition to participant metadata and detailed infection records to;

  1. Uncover novel correlates of protection in older and frail adults, including, but not limited to, ACP, ADCC, and cellular immune responses.
  2. To understand why immune responses are not always protective in older adults and may contribute to subsequent infections.

The successful applicant will have significant leeway to develop an independent research project based on their interests and expertise.  The applicant will work closely with an experienced technician and a graduate student, external collaborators, and will have access to biostatistics expertise.  If interested, there will be opportunities to teach undergraduate courses.

The initial contract will be for one year, with the possibility of extending for more years, depending on productivity. The position is funded, but the applicant will also apply for internal and external funding sources.

About the Bowdish Lab

              The Bowdish Lab is situated at Canada’s most research-intensive university, McMaster University in Hamilton, Ontario Canada. We are a diverse group of undergraduate students, graduate students, technicians and post-doctoral fellows committed to uncovering how the aging immune system changes and understanding why this alters immune responses to vaccination and respiratory infection. For more details on our lab’s philosophy see http://www.bowdish.ca/lab/lab-philosophy/ . We emphasize teamwork, career development, and leadership. Many of our former PDFs have gone on to independent faculty positions in Canada and abroad.

   
Must have;Passion for discovery & evidence of leadership in the form of first-author publications in a relevant field.Team-player with history of collaboration and mentorshipFlow cytometry experienceDeep knowledge of immunity   Nice to have;Experience in human immunology/vaccinologyExperience in antibody quantitation and functional antibody assays (e.g., ADCC, ADP)Experience in intracellular cytokine staining or Experience in science communication with vulnerable populations.

Application process

Please send Dr. Bowdish (bowdish@mcmaster.ca);

  1. A cover letter explaining your interest, skills and career goals and potential start-dates.
  2. A sample of your writing (e.g., first author publication, thesis, other)
  3. C.V.
  4. Names and email addresses of 2 references

Click here for .doc of posting

Publication: Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis

Benoit JM, Breznik JA, Huynh A, Cowbrough B, Baker B, Heessels L, Lodhi S, Yan E, Bhakta H, Clare R, Nazy I, Bramson JL, Larché MJ, Bowdish DM. Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis. Immunol Lett. 2024 Sep 19;270:106929. doi: 10.1016/j.imlet.2024.106929. 

Below is a Bluesky thread that summarizes and explains our manuscript. Click here to read it on Bluesky.

New publication alert! “Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosis” Read on to learn why we did this study and why it is important. 1/n https://www.sciencedirect.com/science/article/pii/S0165247824001032?via%3Dihub

https://bsky.app/profile/msmacrophage.bsky.social/post/3l5zdipjxwe2o

Systemic Sclerosis(SSc) is a rare autoimmune disorder that causes fibrosis of the organs. Because it is caused an immune system gone awry, patients and their doctors were concerned that their immune systems might not respond to the vaccine and leave them less protected 2/n

Because SSC is an autoimmune condition, people generally take immunosuppressive drugs, which can also lead to lower vaccine responses and higher risk of infection. We investigated whether antibody or T cell responses to vaccination were affected in SSC. 3/n

Good news! People with SSC made the same amount of antibodies to the receptor binding domain of the Spike protein (i.e, the bit of the virus that the virus uses to get into us) after their second, third, and fourth SARS-CoV-2 vaccinations. 4/n

More good news! T cell responses to vaccines are thought to help with severe disease and may offer some cross-variant protection. Following the second, third, and fourth SARS-CoV-2 vaccinations, participants with SSc had T cell responses = those without SSC. 5/n

For the immunology geeks: People living with SSc have elevated levels of serum cytokines associated with T cell differentiation. Could this change Th1/2/17/reg mix posts vaccination? Nope. 6/n

Caveat#1: This is a small study (because a rare disease) and we couldn’t investigate all the different drugs that people are on. For more info on how drugs affect vaccination responses see our other studies 7/n https://acrjournals.onlinelibrary.wiley.com/doi/full/10.1002/acr2.11697

Caveat #2: This is very much a comparison of the quantity of immune responses, not the quality. There could still be qualitative differences in immune responses that we didn’t catch but… 8/n

…even though there is very little data on whether SSC is associated with higher infection risk or poorer outcomes what little exists doesn’t find a massive difference compared to the general population 9/n https://acrjournals.onlinelibrary.wiley.com/doi/full/10.1002/acr.25226

Take home message #1: Participants with SSc mount similar responses to SARS-CoV-2 vaccination as controls who do not have autoimmune conditions. 10/n

Take home message #2: Many ppl with autoimmune conditions are afraid that vaccination is unsafe for them because they know their immune system is a bit wonky. It is not the disease that affects immune responses, rather it’s some, not all, drugs at some, not all, doses. 11/n

Thanks to emerging leader & 1st author Jenna Benoit (graduating & looking for a job next year – hint), rheumatologist extraordinaire, Dr. Maggie Larche, cellular immunologist Dr. J. Breznik & J Bramson, team Antibody (Nazy, Huynh) & with special thanks to…..12/n

….our participants. People with SSC often have skin changes which makes blood draws especially hard. Thank you for your commitment to our study and huge props to our exceptional phlebotomist/RC Braeden Cowbrough – our unsung hero. 13/n Fin.

Measles is not a harmless childhood infection – Dr. Bowdish explains.

See Dr. Bowdish’s op-ed piece in the Globe & Mail.

The G&M article is paywalled so you can also read the text below with some additional links to relevant publications:

Dr. Dawn Bowdish is the executive director of the Firestone Institute for Respiratory Health, the Canada Research Chair in Aging and Immunity, and a professor of medicine at McMaster University.

Measles infections are on the rise, particularly in Europe and the U.S., while vaccination rates have declined – but too many have dismissed these trends, seeing measles as just a harmless childhood infection. But it is, in fact, the cause of the most deaths of all the vaccine-preventable infections. Canadian deaths from measles may be rare due to excellent medical care, but measles can have long-term consequences that are worth avoiding.

Before antibiotics were available, measles killed more people than influenza. When a child develops the high fever and rash characteristic of measles, the virus infects and destroys white blood cells, specifically those called lymphocytes. This leads to a period of immune-system suppression, where bacteria that normally live on and inside us without serious issue can cause deadly pneumonia or other infections.

With antibiotics, we can help children through this risky period, although the rise of antibiotic-resistant bacteria means that we can’t be as confident as we once were. What we can’t fix, however, is the damage that measles does to lymphocytes.

Our lymphocytes are essential to the generation of immune responses to new infections and vaccinations, but also in the system’s ability to “remember” the immune responses we’ve already generated. Measles infects and kills these critical immune cells. As a result, we know that a child who contracts measles will probably have more infections and more antibiotic prescriptions for at least five years after their infection, likely because they are getting sick with things that they once had immune protection from. We also know that even as their lymphocyte numbers recover, some are lost and the quality of others are reduced. This is why deaths from many unrelated infections also decreased when the measles vaccines were rolled out; measles no longer caused those children to “forget” their learned immune response.

Measles during pregnancy is dangerous. Miscarriage, premature labour, congenital birth defects, neurodevelopment disorders, or even the death of both mother and baby are all very real possibilities. In some parts of the world, when a woman plans to get pregnant and there is any doubt about her vaccine status, her healthcare provider will test for antibodies to make sure she is protected or recommend vaccination. In Canada, however, this is rare. Pregnant women are often not against being vaccinated, but often feel that not getting vaccinated is safer than getting vaccinated. This, compounded by a well-organized and concerted misinformation campaign about the measles vaccine that began in the 1990s, means that many people born in this era are now entering their child-bearing years having never received their childhood vaccines.

Measles is the most infectious virus we know of, and the increasing number of measles infections locally and globally mean that we can expect to see its tragic effects in pregnancy once again. Midwives, family doctors, and caregivers need to recommend vaccination for measles and other vaccine-preventable infections in the strongest possible terms.

There are some “known unknowns” that make the recent measles outbreaks particularly worrisome. We don’t know whether measles-induced immune suppression will make COVID, respiratory syncytial virus (RSV), streptococcal infections and other surging issues worse. We don’t know what proportion of Canadians have waning measles immunity and whether this means we need booster campaigns. We don’t know if people on immunosuppressant drugs or chemotherapy have lost their protective measles immunity, and if they have, we don’t know if our long-term care homes and cancer centres are at risk of outbreaks – though we do know that our strained healthcare and public health systems are under-resourced and will struggle to cope.

Misinformation, pandemic-related gaps in vaccine delivery, and the continuing countrywide shortages of family doctors means that many Canadians have not been vaccinated. But it’s not too late. The National Advisory Council on Immunization has clear guidance on how people of any age can catch up on their vaccines. If you have any doubt as to whether you were vaccinated, especially if you are thinking about becoming pregnant, speak to your health care provider or public health unit. Even if it turns out you were vaccinated and didn’t know it, there is no safety concern around getting vaccinated again. Children can also be vaccinated if they’ve missed their vaccines for any reason. And we should continue to enforce existing rules that require vaccines to go to school and work in certain sectors.

The terrible consequences of measles in pregnancy and childhood were known to our grandparents and great-grandparents. They are not a lesson that any of us need to learn again.

See also: https://www.nature.com/articles/s41467-018-07515-0